Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Nanotechnology for angiogenesis: opportunities and challenges
S Kargozar, F Baino, S Hamzehlou… - Chemical Society …, 2020 - pubs.rsc.org
Angiogenesis plays a critical role within the human body, from the early stages of life (ie,
embryonic development) to life-threatening diseases (eg, cancer, heart attack, stroke, wound …
embryonic development) to life-threatening diseases (eg, cancer, heart attack, stroke, wound …
Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications
CV Pardeshi, RV Kothawade, AR Markad… - Carbohydrate …, 2023 - Elsevier
Sulfobutylether β-cyclodextrin (SBE-β-CD) is a polyanionic cyclic oligosaccharide that
contains glucopyranose units forming a torus ring-like structure. SBE-β-CD is gifted with …
contains glucopyranose units forming a torus ring-like structure. SBE-β-CD is gifted with …
[HTML][HTML] Combretastatins: an overview of structure, probable mechanisms of action and potential applications
GŞ Karatoprak, E Küpeli Akkol, Y Genç, H Bardakcı… - Molecules, 2020 - mdpi.com
Combretastatins are a class of closely related stilbenes (combretastatins A),
dihydrostilbenes (combretastatins B), phenanthrenes (combretastatins C) and macrocyclic …
dihydrostilbenes (combretastatins B), phenanthrenes (combretastatins C) and macrocyclic …
Nanobubbles for therapeutic delivery: Production, stability and current prospects
DVB Batchelor, FJ Armistead, N Ingram… - Current Opinion in …, 2021 - Elsevier
Nanobubbles (NBs) have recently garnered widespread attention for their potential use as
dual diagnostic and therapeutic agents. Similar to their micron-sized relatives …
dual diagnostic and therapeutic agents. Similar to their micron-sized relatives …
Effect of particle size on the pharmacokinetics and biodistribution of parenteral nanoemulsions
This study aims to investigate the effect of particle size on the pharmacokinetics and
biodistributions of parenteral blank nanoemulsions (NEs). To monitor intact NEs in vivo, a …
biodistributions of parenteral blank nanoemulsions (NEs). To monitor intact NEs in vivo, a …
[HTML][HTML] Horizon: Microfluidic platform for the production of therapeutic microbubbles and nanobubbles
RH Abou-Saleh, FJ Armistead… - Review of Scientific …, 2021 - pubs.aip.org
Microbubbles (MBs) have a multitude of applications including as contrast agents in
ultrasound imaging and as therapeutic drug delivery vehicles, with further scope for …
ultrasound imaging and as therapeutic drug delivery vehicles, with further scope for …
Molecular effects of glycerol on lipid monolayers at the gas–liquid interface: impact on microbubble physical and mechanical properties
RH Abou-Saleh, JR McLaughlan, RJ Bushby… - Langmuir, 2019 - ACS Publications
The production and stability of microbubbles (MBs) is enhanced by increasing the viscosity
of both the formation and storage solution, respectively. Glycerol is a good candidate for …
of both the formation and storage solution, respectively. Glycerol is a good candidate for …
Lipid-stabilized double emulsions generated in planar microfluidic devices
L Kong, A Levin, Z Toprakcioglu, Y Xu, H Gang, R Ye… - Langmuir, 2020 - ACS Publications
Microemulsions have found a wide range of applications exploiting their chemical and
physical properties. Development of microfluidic-based approaches has allowed for the …
physical properties. Development of microfluidic-based approaches has allowed for the …
[HTML][HTML] Targeted microbubbles carrying lipid-oil-nanodroplets for ultrasound-triggered delivery of the hydrophobic drug, combretastatin A4
A Charalambous, V Mico, LE McVeigh… - … , Biology and Medicine, 2021 - Elsevier
The hydrophobicity of a drug can be a major challenge in its development and prevents the
clinical translation of highly potent anti-cancer agents. We have used a lipid-based …
clinical translation of highly potent anti-cancer agents. We have used a lipid-based …
Cytotoxic stilbenes and derivatives as promising antimitotic leads for cancer therapy
C Faustino, AP Francisco, V Isca… - Current Pharmaceutical …, 2018 - ingentaconnect.com
The growing incidence of cancer, the toxic side-effects associated with conventional
chemotherapeutic agents and the development of multidrug resistance (MDR) drive the …
chemotherapeutic agents and the development of multidrug resistance (MDR) drive the …